Weekly Recap | LAEKNA-B +5.13%, obesity pipeline advancesWeekly Review·Nov 14, 2026 at 05:18 AM02105-5.82%
Obesity Week 2026 | Laekna Announces Poster Presentation on LAE124, an Internally Discovered Oral Small-Molecule Amylin Receptor Agonistprnewswire·Nov 12, 2026 at 04:03 AM02105-5.82%
Laekna's Oral Obesity Drug LAE124 Reduces Body Weight in Rat StudiesPUBT·Nov 12, 2026 at 04:02 AM02105-5.82%
Laekna completes Phase I study of LAE103 in overweight or obese participantsPUBT·Nov 9, 2026 at 12:12 AM02105-5.82%
Weekly Recap | LAEKNA-B +6.14%, consensus target above spotWeekly Review·Nov 7, 2026 at 05:44 AM02105-5.82%
LQIDA's AI Edge Push Drives Hong Kong Small-Cap M&A Surge into Tech, BiotechGlobal Report·Oct 28, 2026 at 09:21 AM01361-0.31%008530.00%